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Abstract
Purpose To compare surgical results, morbidity and
positive surgical margins rate of patients undergoing
robotic partial nephrectomy (RPN) versus open partial
nephrectomy (OPN).
Methods This is an observational multicenter study
promoted by the ‘‘Associazione GIovani Laparoscopisti
Endoscopisti’’ (AGILE) no-Profit Foundation, which
involved six Italian urologic centers. All clinical, surgi-
cal, and pathological variables of patients treated with
OPN or RPN for renal tumors were gathered in a pro-
spectively maintained database. Tumor nephrometry was
measured with PADUA score, and complications were
stratified with modified Clavien system. Differences
between RPN and OPN group were assessed with uni-
variate analysis. Perioperative variables independently
associated with complications were assessed with multi-
variate analysis.
Results A total of 198 and 105 patients were enrolled in
OPN and RPN group, respectively. Both had similar
demographics, indications to surgery, tumor nephrometry,
renal function, WIT (18.7 vs. 18.2 min; p = NS), positive
margin rate (5.6 vs. 5.7 %; p = NS), intraoperative com-
plications, and postoperative medical complications.
Compared to OPN, RPN group was significantly more
morbid (p = 0.04), included tumors with smaller size
(p = 0.002), had longer operative time (p \ 0.001), lower
blood loss, surgical postoperative complications (5.7 vs.
21.2 %, p \ 0.001), Clavien 3–4 surgical complications (1
vs. 9.1 %, p = 0.001), and shorter hospitalization. The
surgical approach resulted independently correlated with
surgical complications on multivariate analysis.
Conclusion In the present series, RPN was associated
with a significant reduction of blood loss, surgical com-
plications, including the reintervention rate for urinary
fistula and postoperative bleeding, and with a shorter
hospitalization.
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BMI Body mass index
EBL Estimated blood loss (during
surgery)
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OPN Open partial nephrectomy
PB Postoperative bleeding
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RCC Renal cell carcinoma
RR Related risk
SD Standard deviation
UCS Urinary collecting system
UF Urinary fistula
WIT Warm ischemia time
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Introduction
Open partial nephrectomy (OPN) is the standard treatment
for renal masses up to 7 cm in major dimensions, if tech-
nically feasible [1, 2], since long-term oncological findings
resulted comparable to those of radical nephrectomy [3],
and the preservation of renal function associated with
partial nephrectomy (PN) resulted of crucial importance to
prevent all-cause mortality [4, 5]. Laparoscopic partial
nephrectomy (LPN) and robotic partial nephrectomy
(RPN) are the main mini-invasive alternatives to OPN,
aimed at reducing the added morbidity of an open incision
and potential rib resection. While bringing excellent results
in experienced hands, the diffusion of LPN has been lim-
ited by the technical difficulty and is currently performed in
a few high-volume centers. At contrary, RPN seemed to be
a more reproducible technique, able to bridge the technical
difficulties of LPN in favor of a broader diffusion of
minimally invasive PN. A few well-designed comparative
studies have investigated the perioperative outcomes of
RPN versus those of LPN [6–8], while to date no pro-
spective studies comparing RPN and OPN are available,
but only few retrospective series with limited cases [9–11].
The aim of the present study is to compare the periopera-
tive results and surgical complications of RPN and OPN.
Patients and methods
This is a two-year observational multicenter study pro-
moted by the ‘‘Associazione GIovani Laparoscopisti En-
doscopisti’’ (AGILE) no-profit foundation, which includes a
group of urologists performing in daily practice traditional,
laparoscopic, and robotic surgery in different hospitals.
Between January 2010 and December 2011, the clinical
records of all patients consecutively treated with OPN or
RPN for clinically localized renal cell carcinoma (RCC)
were gathered at six Italian urological centers (Florence,
Udine, Brescia, Abano Terme-PD, Novara, Mantova) and
included in a prospectively maintained database. The
approach selection was based on a chronological criterion,
as the robot was available on 4 centers at the beginning of
the study and in each center at the end. Additional criteria
were patients with preferences for specific approach, or with
significant previous transperitoneal surgery, which have
been treated with OPN. Approval of study protocol by the
local ethical committee was obtained at each center, and
informed consent was collected for all patients.
Surgical technique and surgeons experience
The surgical resection was done by standard partial
nephrectomy, leaving a minimal tumor-free surgical margin
around RCC. Tachosil or Floseal plus surgical bolsters
(Tabotamp) were the hemostatics used in all centers. The
surgical approach was chosen according to surgeons and
centers preferences as well as to the da Vinci system avail-
ability. The surgical complexity and nephrometry score did
not represent criteria for the decision. At the beginning of the
study, all surgeons performing RPN were within the learning
curve (20 cases) [12], but they had previous experience in
LPN, while the surgeons performing OPN had a substantial
previous experience in open kidney surgery ([50 cases).
Robotic partial nephrectomy was done with da Vinci S/Si
Surgical Systems, (Intuitive Surgical, Sunnyvale, USA), all
but one center (Abano Terme-Padua) used a transperitoneal
approach, because it was the preferred and commonly used
access. Patients were placed in flank position. A standard
3-arm approach with a fourth trocar for the assistant and
fifth trocar as needed for right-sided cases was used. The
renal hilum was identified to locate renal artery and vein. In
case of unfavorable position, the kidney was isolated and
rotated in order to perform comfortably the demolitive and
reconstructive phases. Ischemia, if needed, was obtained
with the clamping of renal artery or, according to surgeon’s
preference, with a selective arterial clamping. Hemostasis
in the resection bed was achieved with running sutures
(Monocryl 3-0) preloaded with a Hem-o-lok, brought out-
side through the parenchyma according to the sliding-clip
technique. Care was taken to repair all visible opened
calices and bleeding sites with these running sutures. Usu-
ally, the cortical defect was closed with horizontal inter-
rupted sutures after apposition of hemostatic agents.
Open partial nephrectomy was done using a lateral ret-
roperitoneal approach for all patients. The renal pedicle was
usually controlled en bloc with a vascular clamp. Alterna-
tively, manual compression was used in case of polar lesions
according to center’s preference. Since the warm ischemia
time (WIT) was usually under 25 min, cold ischemia was
never used in this series. Bleeding vessels and incidentally
opened calyces were sutured with 4-0 monofilament running
sutures. The parenchymal defect was closed with horizontal
interrupted sutures after apposition of hemostatic agents.
Data collection
The following patients characteristics were included in the
database: age, gender, body mass index (BMI), American
Society of Anesthesiologists (ASA) score, Charlson index,
and surgical indication. All patients were staged preoper-
atively with computed tomography or magnetic resonance
imaging. The nephrometry of tumors was assessed by the
clinical imaging and measured with PADUA score [13].
The use of pedicle clamping, warm ischemia time (WIT),
total operative time, estimated blood loss (EBL), length of
hospital stay (LOS), including the date of surgery, was
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registered. The blood hemoglobin and serum creatinine
were recorded preoperatively, in first and third postopera-
tive day. The estimated glomerular filtration rate (eGFR)
was calculated with the modification of diet in renal disease
equation [14]. Pathological tumor size, 2009 TNM stage
[15], Fuhrman nuclear grade [16], surgical margin status,
and histological subtypes according to World Health
Organization classification [17] were registered. No central
pathological slide review was performed. All the intra- and
postoperative medical and surgical complications, occur-
ring during surgery and within 30 days, were recorded. The
severity of surgical complications was stratified according
to the modified Clavien system [18]. Postoperative blood
loss was registered in case of reduction [2.5 g/dL in
hemoglobin level (grade 1), and the need of blood trans-
fusions (grade 2), superselective embolization of renal
artery (grade 3a) or of re-intervention (grade 3b–4) was
listed. Urinary fistula was registered if there was persistent
leakage from the drainage beyond sixth postoperative day
and a biochemical analysis of the drain fluid consistent
with urine (drainage fluid-to-serum creatinine ratio greater
than 2). Ureteral stenting was limited to urinary fistula with
persistent leakage beyond tenth postoperative day.
Statistical analysis
Continuous parametric variables are presented as
mean ± standard deviation (SD), nonparametric variables
as median and interquartile range (IQR), and categorical
variables with frequencies and proportions. PADUA score
was analyzed both as nonparametric continuous (3–13)
variable and as a binary with cutoff 10 (\10 vs. C10).
Univariate analysis (Pearson’s v2 test, unpaired t test, and
Mann–Whitney U test, as appropriate) was used to assess
the differences of preoperative variables, surgical results,
and complications between RPN and OPN group. A mul-
tivariate logistic regression model tested the ability of the
surgical approach, along with the other relevant clinical
variables, to predict overall surgical complications and
Clavien grade 3–4 surgical complications, analyzed sepa-
rately. All tests were two-sided, with a statistical signifi-
cance at p \ 0.05. Analyses used all events in Stat view
5.0.1 (SAS Institute Inc. Cary, MC, USA).
Results
Perioperative data are shown in Table 1.
Baseline characteristics
Overall, 302 patients were included. Of them, 198 under-
went OPN and 105 RPN. The OPN and RPN groups were
significantly different in the following preoperative
parameters: clinical tumor size (3.5 ± 1.8 and 2.8 ± 1.5;
p = 0.002) and Charlson index C 2 (5.6 and 25.7 %;
p = 0.04), while imperative indications had a trend of
difference that did not reach the statistical significance (5
versus 1 %, p = 0.07).
Intra- and postoperative outcomes
Clamping of renal vessels was used in 48 % (95/198) of
OPN patients and in 62 % (65/105) of RPN patients. When
used, WIT resulted not significantly different in OPN
versus RPN group (18.7 and 18.2 min, respectively). In
OPN group, the operative time was significantly lower
(p \ 0.0001) and EBL was higher (p = 0.0004). One
robotic procedure was converted to open due to hemor-
rhage, while the total number of intraoperative complica-
tions did not differ between groups. In third postoperative
day, the mean change of hemoglobin was higher in OPN
group (p = 0.0019), while no significant difference resul-
ted in the mean variation of eGFR. Overall, postoperative
complications occurred in 48/198 (24.2 %) patients in OPN
group and in 9/105 (8.6 %) in RPN group (p = 0.009).
About 3 % of patients had medical complications in each
group, thus leaving a higher rate of surgical complications
in OPN versus RPN group (21.2 vs. 5.7 %; p \ 0.0001).
The stratification for severity of surgical complications is
summarized in Table 2. Postoperative bleeding (PB) and
urinary fistula (UF) were the most frequent; in OPN group,
PB occurred in 29/198 (14.6 %) patients; in 21/198
(10.6 %), it was managed with transfusions and in 7/198
(3.5 %) with a second procedure under anesthesia; of these,
4/198 (2 %) were subjected to a superselective emboliza-
tion and 3/198 (1.5 %) to a reintervention. Nephrectomy
was necessary for two patients (1 %), due to the impossi-
bility to stop the bleeding from the resection bed. In OPN
group, the UF occurred in 11/198 (5.5 %) patients. Of
these, 2/198 (1 %) were treated with expectancy, 8/198
(4 %) with the ureteral stent, and one case (0.5 %) was
complicated with renal abscess and required nephrectomy.
Considering the surgical complications of the RPN group,
PB occurred in 5/105 (4.8 %) of patients; in 4/105 (3.8 %),
it was managed with transfusions only, and one patient
(1 %) underwent a superselective embolization. In RPN
group, UF occurred in 1/105 (1 %) patients and was treated
conservatively; no ureteral stenting was needed in robotic
group. No Clavien grade 5 complication occurred in either
group.
Then, we assessed the preoperative variables associated
with surgical complications (Table 3). The clinical tumor
size, the Charlson index, the surgical indication, the
PADUA score, and the surgical approach were signifi-
cantly associated with postoperative surgical complications
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Male gender (%) 62 65.8 Ns
Age (years) mean ± SD 63.8 ± 12.4 62.3 ± 11.6 Ns
Body mass index median (IQR) 26.2 (24.3–29.3) 25.7 (24.0–27.7) Ns
ASA score 3 (%) 14.6 14 Ns
Charlson index C2 (%) 5.6 25.7 0.04
Imperative indication (%) 5.05 1 0.07
Clinical tumor size mean ± SD 3.5 ± 1.8 2.8 ± 1.5 cm 0.002
PADUA score median (IQR) 7 (7–8) 7 (6–7) Ns
No pts. with PADUA C10 (%) 7.1 6.7 Ns
Preoperative Hb (g/dL) mean ± SD 13.9 ± 1.4 14.1 ± 1.2 Ns
Preoperative serum creatinine (mg/dL) mean ± SD 1.0 ± 0.4 0.9 ± 0.2 Ns
Preoperative eGFR (ml/min) mean ± SD 79.0 ± 21.1 89 ± 20.8 Ns
Intraoperative variables
Warm ischemia time (min) mean ± SD 18.7 ± 8.1 18.2 ± 7 Ns
Operative time (min) mean ± SD 123 ± 43 168 ± 56 \0.0001
Estimated blood loss (cc) mean ± SD 230 ± 208 125 ± 128 0.0004
Intraoperative complications (%) 5.1 2.9 Ns
Conversion to open surgery – 1/105 1 % –
Clamping of the renal pedicle 95 (48 %) 65 (62 %) Ns
Pedicle en bloc 95 (48 %)
Artery 53 (50.5 %)
Selective clamping of artery branch 12 (11.5 %)
No clamping 103 (52 %) 40 (38 %)
Surgical results and complications
Variation Hb (preoperative–III postoperative) (g/dL) 3.1 ± 1.9 2.3 ± 1.5 0.0019
Variation (III postoperative–preoperative) serum creatinine 0.2 ± 0.3 0.3 ± 0.1 Ns
Variation eGFR (preoperative–III postoperative) ml/min 8.3 7 Ns
Overall postoperative complications (pts) 48/198 (24.2) % 9/105 (8.6) % 0.009
Surgical postoperative complications (pts) 42/198 (21.2) % 6/105 (5.7) % \0.0001
Postoperative bleeding 29 (14.6 %) 5 (4.8 %)
Urinary fistula 11 (5.6 %) 1 (1 %)
Intestinal lesions 2 (1 %) 0
Medical postoperative complications (pts) 6/198 (3.0) % 3/105 (2.9) % Ns
Cardiovascular 4 (2 %) 3 (2.9 %)
Respiratory 2 (1 %) 0
Clavien grade 3–4 surgical complications (pts) 18/198 (9.1) % 1/105 (1) % 0.001
Length of hospital stay, including the date of surgery
Days median (IQR)
7 (5–10) 5 (4–6) 0.042
Pathological data
Pathological histotype (%)
Benign 42 (21.2 %) 14 (13.3 %) NS
Malignant 156 (78.8 %) 91 (86.7 %)
Clear cell 116 (58.6 %) 64 (61.0 %)
Papillary 18 (9.1 %) 12 (11.4 %)
Chromophobe 17 (8.6 %) 11 (10.5 %)
Other malignant 5 (2.5 %) 4 (3.8 %)
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at the univariate analysis (data not shown), while the
avoidance of pedicle clamping was not correlated with
postoperative surgical complications (p = 0.59). On the
multivariate analysis, only the imperative indication
(RR = 3.9; p = 0.050) and the open surgical approach
(RR = 3.8; p = 0.005) resulted independently associated
with postoperative surgical complications. Finally, surgical
approach (RR = 9.4; p = 0.03) was the only variable
independently associated with Clavien grade 3–4 surgical
complications.
Discussion
In recent years, many papers compared the perioperative
results of RPN and LPN, and current evidence suggests that
RPN can reproduce the advantages of mini-invasiveness
with a shorter learning curve, since it entails excellent
perioperative outcomes after about 30 cases [12]. In some
studies, it was found that RPN may decrease WIT, opera-
tive time and EBL [7, 19, 20], and in a recent series also the
incidence of complications, compared to LPN [6].
Ideally, every surgical option for the conservative
treatment of renal tumors should be compared to OPN that
is the matching standard of treatment and has the robust-
ness of data regarding surgical and oncological results [21].
To our knowledge, this is the second prospectively derived
comparative study of perioperative outcomes of RPN and
OPN. In accordance with our results, in the previous study,
Simhan et al. [9] reported after RPN comparable WIT and
eGFR modification, with shorter hospitalization. These
data suggest that RPN may replicate the rapidity of the
open approach in the more complex phase of intervention,
also leading to comparable early functional results.
Table 2 Stratification for
severity of postoperative
surgical complications of RAPN
versus OPN group with
modified Clavien system
a One case of inadvertent lesion
of the descendent colon in a
kidney extensively attached to








Clavien-Dindo grade 1 3 (1.5 %) 1 (1 %)
Drainage leakage treated with expectancy 2 (1 %) 1 (1 %)
Slight blood loss treated with bedrest 1 (0.5 %) 0
Clavien-Dindo grade 2 21 (10.6 %) 4 (3.8 %)
Blood loss treated with homologous blood transfusions 21 (10.6 %) 4 (3.8 %)
Clavien-Dindo grade 3 15 (7.6 %) 1 (1 %)
Urinary fistula treated with ureteral stenting 8 (4 %) 0
Blood loss treated with superselective hembolization 4 (2 %) 1 (1 %)
Reintervention due to hemorrhage 1 (0.5 %) 0
Intestinal lesions treated with reintervention 2 (1 %)a 0
Clavien-Dindo grade 4 3 (1.5 %) 0
Nephrectomy due to hemorrhage 2 (1 %) 0










pT1a 112 (56.6 %) 73 (69.5 %)
pT1b 24 (12.2 %) 7 (6.6 %)
pT2a–b 8 (4.0 %) 1 (1 %)
pT3a 12 (6.0 %) 10 (9.6 %) NS
Fuhrman nuclear grade (%)
G1 28 (14.2 %) 23 (21.9 %)
G2 105 (53.0 %) 55 (52.4 %)
G3–G4 23 (11.6 %) 13 (12.4 %)
Positive surgical margin 11 (5.6 %) 6 (5.7 %) NS
Univariate analysis with Pearson’s chi-square test, unpaired t test, and Mann–Whitney U test, as appropriate
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However, a previous study on this issue by Lee and col-
leagues reported a longer WIT in the RPN group (23 vs.
19 min, p \ 0.001) [11]. It is not easy to justify this het-
erogeneity of results. Surely, the increasing surgeons
experience in RPN may lead to a progressive reduction in
WIT in the most recent series.
Interestingly, in the present series that evaluated all cases
of PN regardless the nephrometry score, the robotic
approach also resulted in a significant reduction of post-
operative surgical morbidity. This is not in agreement with
Simhan, which in tumors with moderate–high complexity
according to RENAL score reported comparable postoper-
ative complications [9]. This might suggest that benefits in
terms of surgical morbidity of RPN are best expressed in
tumors of low complexity, although this hypothesis cannot
be supported by ourselves. In fact, in a subanalysis of
patients with moderate–high nephrometry (PADUA
score C 8), not shown in the results section, the advantages
of RPN in terms of overall postoperative complications
remained significant (8 vs. 29.9 %; p = 0.026). A possible
explanation for the reduction of complications might be the
better visualization of the resection bed in resulting of a
better closure of vessels and/or urinary collecting system.
Prospective studies with larger series are needed to further
elucidate this issue, and to confirm whether or not RPN has
a lower surgical morbidity than OPN, as previously shown
in comparison with LPN [6]. In our study, the advantages of
RPN regarding the surgical morbidity could have been
partially overestimated, due to a not negligible postopera-
tive complications rate in the OPN group (24.2 %) and to a
favorable complication rate in the RPN group that are,
however, within the ranges reported in the literature
(9.6–30.7 and 8–22 % for OPN and RPN, respectively) [22–
26]. Also our rate of acute or delayed postoperative hem-
orrhage requiring reintervention (3 %) and of urinary fis-
tulas (5.5 %) after OPN are within the ranges reported in the
literature, 1.3–7.9 % [24, 27, 28] and 1.4–17.4 % [23, 29],
respectively. Also Lee et al., in their retrospective study of
OPN versus RPN, reported a higher overall postoperative
complications rate in the open group (15.4 and 8.7 %,
respectively; p = 0.158) although without reaching the
statistical significance, possibly due to the relatively low
number of patients in RPN group (n = 69). None of the
previous comparisons between OPN and RPN subdivided
postoperative complications into medical and surgical; in
our series, the difference in postoperative complications
was solely related to surgical morbidity, while no difference
in medical complications was found, although RPN group
had an higher Charlson index at baseline.
The oncological outcomes of RPN are usually presented
using surrogate endpoints such as the PSM rate. Our PSM
rate in RPN group was not higher than OPN, and both were
within the range reported in the literature (0–7 %).
We acknowledge some limitations to the present study.
First, surgeons experience was higher in the open group.
This is an intrinsic bias of studies, which compare a new
technique with the standard treatment. Moreover, tumor
diameter was higher in OPN group. Nevertheless, tumor
nephrometry was homogeneous, and in previous analyses,
it resulted a stronger predictor of complications compared
to tumor diameter [30]. The strengths of the present study
are inherent to the prospective data collection, to the
multicenter nature, to the strict definition of any compli-
cation that was decided before the data recording, and to
the separate analysis of medical and surgical complica-
tions. This approach might increase the external validity of
the data compared with the single-center, single-surgeon
setting, reflecting a ‘‘real world’’ scenario.
The present experience evaluated the perioperative
results only; future studies with appropriate follow-up will
assess the differences of oncological and long-term func-
tional outcomes between RPN and OPN.
Conclusion
In our analysis, RPN resulted comparable to OPN in terms
of WIT and PSM rate, and showed a reduction of bleeding,
Table 3 Multivariate analysis (logistic regression) of preoperative variables to predict surgical complications and Clavien grade 3–4 surgical
complications after partial nephrectomy
Preoperative variable Postoperative surgical complications Postoperative Clavien-Dindo grade 3–4 surgical complications
Risk ratio p value 95 % CI Risk ratio p value 95 % CI
Clinical tumor size 1.15 0.15 0.95–1.4 1.5 0.22 0.9–1.5
Charlson index C 2 0.5 0.1 0.2–1.15 0.6 0.46 0.19–2.13
Imperative indication 3.9 0.050 1.0–16.0 3.1 0.21 0.5–20.1
PADUA score C10 0.9 0.90 0.25–3.4 1.04 0.96 0.17–6.1
Technique open versus robotic 3.8 0.005 1.5–9.5 9.4 0.03 1.2–72.9
Use of ischemia 0.9 0.78 0.5–1.8 0.9 0.46 0.19–2.13
PADUA preoperative aspects and dimensions used for anatomical classification of renal tumor
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postoperative surgical complications, and hospitalization.
Operative time was significantly higher in RPN group.
Conflict of interest None.
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